Trademark: 97263745
Word
OTWILLO
Status Date
Friday, June 28, 2024
Filing Date
Friday, February 11, 2022
Published for Opposition
Tuesday, January 3, 2023
OT4B -
Owner At Publication
5 Drug delivery agents in the form of transdermal patches, creams, gels, lotions, ointments, capsules, liquids, tablets, and oral transmucosals that facilitate the delivery of pharmaceutical and biological preparations; pharmaceutical and biological preparations for use in treatment of Prader-Willi syndrome and other neuro developmental disorders; Medicines for human purposes, for treatment of Prader-Willi syndrome and other neuro developmental disorders
Feb 15, 2022
New Application Entered
Feb 16, 2022
New Application Office Supplied Data Entered
Nov 28, 2022
Assigned To Examiner
Nov 28, 2022
Approved For Pub - Principal Register
Dec 14, 2022
Notification Of Notice Of Publication E-Mailed
Jan 3, 2023
Published For Opposition
Jan 3, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2023
Sou Teas Extension Received
Jul 12, 2023
Sou Extension 1 Filed
Jul 12, 2023
Sou Extension 1 Granted
Jun 28, 2024
Sou Teas Extension Received
Jun 28, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 28, 2024
Sou Extension 3 Filed
Jun 28, 2024
Sou Extension 3 Granted
Feb 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2024
Sou Teas Extension Received
Feb 7, 2024
Sou Extension 2 Filed
Feb 7, 2024
Sou Extension 2 Granted
Trademark Alertz updated from USPTO on 2030-01-24
